CoChat

GSK‐3 activity in neocortical cells is inhibited by lithium but not carbamazepine or valproic acid

Open access
Jonathan Ryves, W, Dalton, Emma C, Harwood, Adrian J, Williams, Robin SB · 2005 · Bipolar Disorders
Cited by 60

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Objectives: Lithium (Li+) has been suggested to target the enzyme glycogen synthase kinase 3 (GSK‐3) as a mechanism of mood stabilization. Inhibition of GSK‐3 by a second mood‐stabilizer, valproic acid (VPA), has also been reported, but this effect is dependent on cell type. It is currently unknown if carbamazepine (CBZ) inhibits GSK‐3 activity. We have sought to compare the inhibitory effect of Li+, VPA and CBZ on GSK‐3 activity. Methods: We treated rat primary cultured neurones at three times therapeutic drug concentration with CBZ, VPA and Li+ and examined changes in GSK‐3 protein levels, activity and phosphorylation of downstream targets. To eliminate a possible direct effect of these drugs at higher concentrations, we also looked for direct inhibition of both GSK‐3 isoforms at a range of concentrations. Results: CBZ, VPA and Li+ did not change the levels of the GSK‐3 or produce an irreversible in vivo effect on GSK‐3 activity. Only Li+ inhibited the phosphorylation of a cytoskeletal target of GSK‐3, tau, whereas CBZ and VPA did not. Surprisingly, none of these drugs altered β‐catenin levels in these cells, a process attenuated by GSK‐3 activity. Finally, only Li+ directly inhibits GSK‐3 activity (both α and β isoforms) at therapeutic levels in direct biochemical assays. Conclusion: Thus we show that neither GSK‐3 nor the altered GSK‐3 signalling pathway can provide a common mechanism of action of mood‐stabilizing drugs in the mammalian brain.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1399-5618.2005.00194.x

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 60

Metadata

Authors
Jonathan Ryves, W., Dalton, E. C., Harwood, A. J., & Williams, R. S.
Venue
Bipolar Disorders
Publisher
Wiley
Published
2005-05-17
Volume
7
Issue
3
Pages
260-265
ISSN
  • 1398-5647 (ISSN-L)
  • 1399-5618
OpenAlex
W2134773980
Cited by
60
References
3
FWCI
2.02
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: GSK‐3 activity in neocortical cells is inhibited by lithium but not carbamazepine or valproic acid. https://app.cochat.ai/papers/10.1111/j.1399-5618.2005.00194.x
The paper
Jonathan Ryves, W., Dalton, E. C., Harwood, A. J., & Williams, R. S. (2005). GSK‐3 activity in neocortical cells is inhibited by lithium but not carbamazepine or valproic acid. Bipolar Disorders. https://doi.org/10.1111/j.1399-5618.2005.00194.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.